Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific optimal pH and stability data for HEPTAPEPTIDE-35 are not available. However, peptides generally exhibit pH-dependent stability, with some showing extended half-lives at lower pH values (e.g., pH 5). Optimal dissolution typically occurs at near-neutral pH (6-8) due to increased charge distribution. Effective solubilization, pH optimization, and appropriate buffering are crucial for maintaining peptide stability in aqueous formulations.
Safety
Safety Profile
No specific safety assessments for HEPTAPEPTIDE-35 have been conducted by CIR, SCCS, or FDA. While some peptides, such as Acetyl Hexapeptide-8 Amide, have been deemed safe in cosmetics at concentrations up to 0.005%, data for higher concentrations remain insufficient. Concerns have been raised by the FDA regarding immunogenicity for other heptapeptides (e.g., Semax) in compounded drugs, citing potential for aggregation and impurities, and a general lack of human safety data for certain administration routes. The SCCS has also been unable to complete safety assessments for other complex heptapeptides due to limited or absent essential information.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a complete lack of specific clinical efficacy data, mechanism of action, and comprehensive safety assessments, the cosmetic utility of HEPTAPEPTIDE-35 cannot be reliably determined at this time.
Related
Similar Ingredients
Finding similar ingredients…